Study author Surbhi Singhal, MD, is an assistant professor in the Division of Oncology at the University of California Davis and thoracic medical oncologist at the UC Davis Comprehensive Cancer Center.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).